Spots Global Cancer Trial Database for ovarian cancer, epithelial
Every month we try and update this database with for ovarian cancer, epithelial cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
A Study of NX-1607 in Adults With Advanced Malignancies | NCT05107674 | Ovarian Cancer,... Gastric Cancer GastroEsophagea... Head and Neck S... Metastatic or U... Non-small Cell ... Metastatic Cast... Malignant Pleur... Triple Negative... Metastatic Urot... Cervical Cancer Diffuse Large B... Richter Transfo... Microsatellite ... | NX-1607 Paclitaxel | 18 Years - | Nurix Therapeutics, Inc. | |
Phase 1, First-in-human, Dose-finding and Expansion Study to Evaluate XmAb®808 in Combination With Pembrolizumab in Advanced Solid Tumors | NCT05585034 | Head and Neck S... Melanoma Exclud... Non-small Cell ... Urothelial Carc... Renal Cell Carc... Castration-resi... Ovarian Cancer,... TNBC - Triple-N... Colorectal Canc... | XmAb®808 Keytruda® (pemb... | 18 Years - | Xencor, Inc. | |
A Randomized Prospective Trail of HIPEC in Recurrent Ovarian Cancer Patients With HRR Mutation | NCT04473339 | Ovarian Cancer Epithelial Ovar... Ovarian Cancer,... Hyperthermic In... Homologous Reco... | CRS+HIPEC CRS alone | 18 Years - 75 Years | Zhongnan Hospital | |
Prospective Randomized Trial of Streamlined Genetic Education and Testing for Ovarian Cancer Patients | NCT04537702 | Ovarian Cancer,... Peritoneal Canc... Fallopian Tube ... | Streamlined Edu... Traditional Edu... | 18 Years - | Duke University | |
A Randomized Prospective Trail of HIPEC in Recurrent Ovarian Cancer Patients With HRR Mutation | NCT04473339 | Ovarian Cancer Epithelial Ovar... Ovarian Cancer,... Hyperthermic In... Homologous Reco... | CRS+HIPEC CRS alone | 18 Years - 75 Years | Zhongnan Hospital | |
Cytoreductive Surgery(CRS) Plus Hyperthermic Intraperitoneal Chemotherapy(HIPEC) With Lobaplatin in Advanced and Recurrent Epithelial Ovarian Cancer | NCT03371693 | Ovarian Cancer Ovary Neoplasm Ovarian Neoplas... Epithelial Ovar... Ovarian Cancer,... Hyperthermic In... | HIPEC CRS IVCT | 18 Years - 75 Years | Zhongnan Hospital | |
Envafolimab, Lenvatinib Combined With VP-16 in Platinum-resistant Recurrent Epithelial Ovarian Cancer | NCT05422183 | Ovarian Cancer,... | Envafolimab Lenvatinib VP-16 | 18 Years - | Zhongda Hospital | |
A Randomized Prospective Trail of HIPEC in Recurrent Ovarian Cancer Patients With HRR Mutation | NCT04473339 | Ovarian Cancer Epithelial Ovar... Ovarian Cancer,... Hyperthermic In... Homologous Reco... | CRS+HIPEC CRS alone | 18 Years - 75 Years | Zhongnan Hospital |